Whitney & Co’s ResMed RMD Stock Holding History

Whitney & Co’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11M	Sell	48,848 -133	-0.3%	-$33.1K	0.91%	36
2025 Q4	$11.8M	Sell	48,981 -547	-1%	-$140K	0.94%	35
2025 Q3	$13.6M	Sell	49,528 -4,003	-7%	-$1.09M	1.23%	24
2025 Q2	$13.8M	Buy	53,531 +1,043	+2%	+$249K	1.36%	24
2025 Q1	$11.7M	Buy	52,488 +1,496	+3%	+$349K	1.25%	27
2024 Q4	$11.7M	Sell	50,992 -6,463	-11%	-$1.56M	1.22%	28
2024 Q3	$14M	Buy	57,455 +1,111	+2%	+$248K	1.5%	25
2024 Q2	$10.8M	Buy	56,344 +25,376	+82%	+$5.15M	1.24%	29
2024 Q1	$6.13M	Buy	30,968 +2,099	+7%	+$385K	0.73%	45
2023 Q4	$4.97M	Buy	+28,869	New	+$4.44M	0.64%	46
2018 Q4	–	Sell	-175	Closed	-$19K	–	375
2018 Q3	$19K	Buy	+175	New	+$19.2K	﹤0.01%	250

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitney & Co's RMD Position: Q1 2026 in Review

Whitney & Co reduced its ResMed (RMD) stake by 0.27% in Q1 2026, selling an estimated $33.1K and leaving 48,848 shares worth $11M. The position accounts for 0.91% of the portfolio, ranked #36.

Whitney & Co first reported a position in RMD in Q3 2018 and has held it in 11 quarters since. The position peaked at $14M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Whitney & Co held 48,848 shares of ResMed worth $11M as of Q1 2026.
Whitney & Co sold 133 ResMed shares in Q1 2026, an estimated $33.1K.
ResMed made up 0.91% of Whitney & Co's portfolio in Q1 2026, its #36 holding.
Whitney & Co first reported a position in ResMed in Q3 2018 and has held it in 11 quarters since.
Whitney & Co's ResMed position peaked at $14M in Q3 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Whitney & Co's 13F filing for Q1 2026, filed 5 May 2026.